Glucocorticoids and placental programming

The Placenta and Human Developmental Programming

Volumn , Issue , 2010, Pages 175-187

  Vaughan, Owen R ^a   Forhead, Alison J ^a   Fowden, Abigail L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83155194046     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511933806.015     Document Type: Chapter

References (78)

1. Barker DJP. Mother, Babies and Disease in later Life. London: BMJ Publishing Group, 1994.
2. McMillen IC, Robinson JC. Developmental origin of the metabolic syndrome; prediction, plasticity and programming. Physiol Rev 2005; 85: 571–633.
3. Fowden AL, Ward JW, Wooding FPB, Forhead AJ, Constancia M. Programming placental nutrient transfer capacity. J Physiol 2006; 572: 5–15.
4. Fowden AL, Forhead AJ, Coan PM, Burton GJ. The placenta and intrauterine programming. J Neuroendocrinol 2008; 20: 439–50.
5. Seckl JC. Glucocorticoids, developmental programming and the risk of affective dysfunction. Prog Brain Res 2008; 167: 17–34.
6. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: are there long term consequences of the life insurance? Proc Nutr Soc 1998; 57: 113–22.
7. Fowden Al, Forhead AJ. Hormones as epigenetic signals in developmental programming. Exp Physiol 2009; 94: 607–25.
8. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005; 81: 723–34.
9. Seckl JC. Glucocorticoids, fetoplacental 11_-hydroxysteroid dehydrogenase type 2 and early life origins of adult disease. Steroids 2001; 62: 89–94.
10. McMillen IC, Thorburn GD, Walker DW. Diurnal variations in plasma concentrations of cortisol, prolactin, growth hormone and glucose in the fetal sheep and pregnant ewe during late gestation. J Endocrinol 1987; 114: 65–72.
11. Fowden AL, Mundy L, Silver M. Developmental regulation of glucogenesis in the sheep fetus during late gestation. J Physiol 1998; 508: 937–47.
12. Fletcher AJW, Gardner DS, Edwards CMB, Fowden Al, Giussani, DA. Cardiovascular and endocrine responses to acute hypoxaemia during and following dexamethasone infusion in the ovine fetus. J Physiol 2003; 549: 271–87.
13. Fowden, AL, Forhead AJ, Ousey, JC. The endocrinology of equine parturition. Exp Clin Endocrinol Diabetes 2008; 116: 393–403.
14. Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004; 127: 515–26.
15. Hennessy DP, Coghlan JP, Hardy KJ, Scoggins BN, Wintour EM. The origin of cortisol in the blood of fetal sheep. J Endocrinol 1982; 95: 71–9.
16. Waddell BJ, Benediktsson R, Brown RW, Seckl JR. Tissue-specific messenger ribnucleic acid expression of 11_-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within the rat placenta suggest exquisite local control of glucocorticoid action. Endocrinology 1998; 139: 1517–23.
17. Speirs HJL, Seckl JR, Brown RW. Ontogeny of glucocorticoid receptor and 11_-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J Endocrinol 2004; 181: 105–16.
18. Whittle WL, Holloway AC, Lye S, Challis JR, Gibb W. The pattern of glucocorticoid and estrogen receptors may explain differences in steroid dependency of intrauterine prostaglandin production at parturition in sheep. J Soc Gynecol Invest 2006; 13: 506–11.
19. Johnson RF, Rennie N, Murphy V et al. Expression of glucocoticoid receptor messenger ribonucleic acid transcripts in the human placenta at term. J Clin Endocrinol Metab 2008; 93: 4887–93.
20. Ward IL, Weisz J. Differential effects of maternal stress on circulating levels of corticosterone, progesterone and testosterone in male and female rat fetuses and their mothers. Endocrinol 1984; 114: 1635–44.
21. Barbazanges A, Piazza PV, LeMoal M, Maari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 1996; 16: 3943–49.
22. Gardner DS, Jackson AA, Langley-Evans SC. The effect of prenatal diet and glucocorticoids on growth and systolic blood pressure in the rat. Proc Nutr Soc 1997; 57: 235–40.
23. Langley-Evans SC, Benediktsson R, Gardner DS, Jackson AA, Seckl JR. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension. Placenta 1997; 17: 169–72.
24. McMullen S, Ogersby JC, Thurston LM et al. Alterations in 11_-hydroxysteroid dehydrogenase (11_HSD) activities and fetal cortisol: cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation. Reproduction 2004; 127: 17–25.
25. Clifton VL, Rennie N, Murphy VE. Effects of inhaled glucocorticoid treatment on placental 11_-hydroxysteroid dehydrogenase type 2 activity and neonatal birth weight in pregnancies complicated by asthma. Aust NZ J Obstet Gynaecol 2006; 46: 136–40.
26. American College of Obstericians and Gynecologists. ACOG Committee Opinion 402. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2008; 111: 805–7.
27. Baisden B, Sonne S, Joshi RM, Ganapathy V, Shekhaurat PS. Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta. Placenta 2007; 28: 1082–90.
28. Vaughan OR, Sferruzzi-Perri AN, Coan PM, Burton GJ, Fowden AL. Effects of dexamethasone treatment on amino acid clearance and diffusional exchange capacity of the mouse placenta depends on gestational age. Placenta 2009; 30: A11.
29. Hahn T, Barth S, Graf R et al. Placental glucose transporter expression is regulated by glucocorticoids. J Clin Endocrinol Metab 1999; 84: 1445–52.
30. Shafrir E, Barash V, Zederman R, Kisselevitz R, Diamant TZ. Modulation of fetal and placental metabolic pathways in response to maternal thyroid and glucocorticoid hormone excess. Isr J Med Sci 1994; 30: 32–41.
31. McDonald TJ, Franko KL, Brown JM et al. Betamethasone in the last week of pregnancy causes fetal growth retardation but not adult hypertension in rats. J SocGynecol Invest 2003; 10: 469–73.
32. Franko KL, Forhead AJ, Fowden AL. Differential effects of prenatal stress and glucocorticoid administration on postnatal growth and glucose metabolism in rate. J Endocrinol 2010; 204: 319–29.
33. Ain R, Canham LN, Soares MJ. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the AKT signalling pathway. J Endocrinol 2005; 185: 253–63.
34. Sugden MC, Langdown ML, Munns MJ, Holness MJ. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and maternofetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 2001; 145: 529–39.
35. Burton BJ, Waddell BJ. 11β-hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J Endocrinol 1994; 143: 505–13.
36. Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006; 147: 5568–74.
37. Barrada MI, Blomquist CH, Kotts MS. The effects of betamethasone on fetal development in the rabbit. Am J Obstet Gynecol 1980; 136: 234–8.
38. Jensen EC, Gallaher BW, Breien BH, Harding JE. The effect of chronic maternal cortisol infusion on the late-gestation fetal sheep. J Endocrinol 2002; 174: 27–36.
39. Braun T, Li S, Moss TJM et al. Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep. J Endocrinol 2007; 194: 337–47.
40. Kutzler MA, Ruane EK, Coksaygan T, Vincent SE, Nathanielsz PW. Effects of three couses of maternally administered dexamethasone at 0, 7, 0.75 and 0.8 of gestation on prenatal and postnatal growth in sheep. Pediatrics 2004; 113: 313–19.
41. Johnson JWC, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: multisystemic effects. Am J Obstet Gynecol 1979; 133: 677–84.
42. Epstein MF, Farrell PM, Sparks JW et al. Maternal betamethasone and fetal growth and development in the monkey. Am J Obstet Gynecol 1977; 27: 1261–3.
43. Smith JT, Waddell BJ. Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology 2003; 144: 3024–30.
44. Wyrwoll CS, Seckl JC, Megan MC. Altered placental function of the 11_-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009; 150: 1287–93.
45. Mandl M, Ghaffari-Tabrizi N, Haas J, Nohammer G, Desoye G. Differential glucocorticoid effects on proliferation and invasion of human trophoblast cell lines. Reproduction 2006; 132: 159–67.
46. Audette MC, Greenwood SL, Sibley CP et al. Dexamethasone stimulates placental system A transport and trophoblast differentiation in term villous explants. Placenta 2010; 31: 97–105.
47. Ward JW, Forhead AJ, Wooding FBP, Fowden AL. Functional significance and cortisol dependence of the gross morphology of ovine placetomes during late gestation. Biol Reprod 2006; 74: 137–45.
48. Ward JW, Wooding FBP, Fowden AL. The effect of cortisol on the binucleate cell population in the ovine placenta during late gestation. Placenta 2002; 23: 451–8.
49. Wooding FPB, Burton GJ. Comparative Placentation; Structure, Functions and Evolution. Heidelberg: Springer-Verlag, 2008.
50. Mayhew TM, Jenkins H, Todd B, Clifton VL. Maternal asthma and placental morphology: effects of severity, treatment and fetal sex. Placenta 2008; 29: 366–73.
51. Ward JW, Wooding FPB, Fowden AL. Ovine fetoplacental metabolism. J Physiol 2004; 554: 529–41.
52. Jellyman JK, Gardner DS, Fowden AL, Giussani DA. Effects of dexamethasone on the uterine and umbilical vascular beds during basal and hypoxemic conditions in sheep. Am J Obstet Gynecol 2004; 190: 825–35.
53. Kutzler MA, Coksaygan TC, Ferguson AD, Nathanielsz PW. Effects of maternally administered dexamethasoneand acute hypoxemia at 0.7 gestation on blood pressure and placental perfusion in sheep. Hypertens Pregnancy 2004; 23: 75–90.
54. Miller SL, Supramaniam VG, Jenkin G, Walker DW, Wallace EM. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus. Am J Obstet Gynecol 2009; 201: 613e1–8.
55. Cohlen BJ, Stigter RH, Derks JB, Mulder EJ, Visser GH. Absence of significant hemodynamic changes in the fetus following maternal betamethasone administration. Ultrasound Obstet Gynecol 1996; 8: 252–5.
56. Franko KL, Giussani DA, Forhead AJ, Fowden AL. Effects of dexamethasone on the glucogenic capacity of fetal, pregnant and non-pregnant adult sheep. J Endocrinol 2007; 191: 67–3.
57. Milley JR. Fetal substrate uptake during increased ovine cortisol concentration. Am J Physiol 1996; 271: E186–E191.
58. Timmerman M, Teng C, Wilkening RB et al. Effect of dexamethasone on fetal hepatic glutamine-glutamate exchange. Am J Physiol 2000; 278: E839–E845.
59. Langdown ML, Sugden MC. Enhanced placental GLUT1 and GLUT3 expression in dexamethasone induced fetal growth retardation. Mol Cell Endocrinol 2001; 185: 109–17.
60. Jones HN, Ashworth CJ, Page KR, McArdle HJ. Cortisol stimulates system A amino acid transport and SNAT2 expression in human placental cell lines (BeWo). Am J Physiol 2006; 291: E596–603.
61. Coan PM, Vaughan OR, Sekita Y et al. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol 2010; 588: 527–38.
62. Coya R, Gualillo O, Pineda J et al. Effect of cyclic 3', 5'-adenosine monophosphate, glucocoticoids, and insulin on leptin messenger RNA levels and leptin secretion in cultured human trophoblast. Biol Reprod 2001; 65: 814–19.
63. Whittle WL, Patel FA, Alfraidy N et al. Glucocorticoid regulation of human and ovine parturition: the relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production. Biol Reprod 2001; 64: 1019–32.
64. Challis JRG, Sloboda D, Matthews SC et al. Prostaglandins and mechanisms of preterm birth. Reproduction 2002; 124: 1–17.
65. Liggins GC, Scroop GG, Haughey KG. Comparison of the effects of prostaglandin E2, prostacyclin and 1–24 adrenocorticotrophin on plasma cortisol levels of fetal sheep. J Endocrinol 1982; 95: 153–62.
66. Mirazi N, Alfraidy N, Martin R, Challis JRG. Effects of dexamethasone and sulfasalazine on prostaglandin E2 output by human placental cells in vitro. J Soc Gynocol Invest 2004; 11: 22–6.
67. Fowden AL, RalphM, SilverM. Nutritional regulation of uteroplacental prostaglandin production and metabolism in pregnant ewes and mares during late gestation. Exp Clin Endocrinol 1994; 102: 212–21.
68. Clarke K, Ward JW, Forhead AJ, Giussani DA, Fowden AL. Regulation of 11_-hydroxysteroid dehydrogenase type 2 (11β-HSD2) activity in ovine placenta by fetal cortisol. J Endocrinol 2002; 172: 527–34.
69. Kerzner LS, Stonestreet BS, Wu K-Y, Sadowska G, Malee MP. Antenatal dexamethasone: effect on ovine placental 11β -hydroxysteroid dehydrogenase type 2 expression and fetal growth. Pediatr Res 2002; 52: 706–12.
70. Vackova Z, Vagnernova K, Libra A. Dexamethasone and betamethasone administration during pregnancy affects the expression and function of 11β-hydroxysteroid dehydrogenase type 2 in the rat placenta. Reprod Toxicol 2009; 28: 46–51.
71. Mairesse J, Lesage J, Breton C et al. Maternal stress alters endocrine function of the fetoplacental unit in rats. Am J Physiol 2007; 292: E1526–E1533.
72. Ma XH, Wu WX, Nathanielsz PW. Gestation-related and betamethasone-induced changes in 11β-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta. Am J Obstet Gynecol 2003; 188: 13–21.
73. Mark PJ, Sheldon S, Lewis JL, Hewitt D, Waddell BJ. Changes in the placental glucocorticoid barrier during rat pregnancy: Impact on placental corticosterone levels and regulation by progesterone. Biol Reprod 2009; 80: 1209–15.
74. Fowden AL, Sibley C, Reik C, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res 2006; 65: 49–57.
75. Verhaeghe J, van Bree R, Van Herck E. Oxidative stress after antenatal betamethasone: acute downregulation of glutathione peroxidase-3. Early Hum Dev 2009; 85: 767–71.
76. Fowden AL.The insulin-like growth factors and fetoplacental growth. Placenta 2003; 24: 803–12.
77. Constancia M, Angiolini E, Sandovici I et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. PNAS 2005; 102: 19219–24.
78. Coan PM, Fowden AL, Constancia M et al. Disproportionate effects of Igf2 gene knockout on placental morphology and diffusional exchange characteristics in the mouse. J Physiol 2008; 586: 5023–32.